EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer

Published:2014-06-26 Issue:5 Volume:192 Page:759-763
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Bar Jair,Cyjon Arnold,Flex Dov,Sorotsky Hadas,Biran Haim,Dudnik Julia,Peylan-Ramu Nili,Peled Nir,Nechushtan Hovav,Gips Maya,Katsnelson Rivka,Rosenberg Shoshana Keren,Merimsky Ofer,Onn Amir,Gottfried Maya

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00408-014-9604-7.pdf

Reference18 articles.

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66

2. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497–1500

3. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129–2139

4. Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E (2012) Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(7):56–64

5. Rekhtman N, Paik PK, Arcila ME, Tafe LJ, Oxnard GR, Moreira AL, Travis WD, Zakowski MF, Kris MG, Ladanyi M (2012) Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin Cancer Res 18:1167–1176

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets;OncoTargets and Therapy;2021-09

2. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review;Genetics in Medicine;2020-09

3. Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations;Precision Clinical Medicine;2019-11-22

4. Clinical Impact of Hybrid Capture–Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer;Journal of Thoracic Oncology;2017-02

5. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors;Tumor Biology;2015-08-14